Word

MATRICELF

Status

Pending

Status Code

641

Status Date

Thursday, July 25, 2024

Serial Number

79391456

Mark Type

4

Filing Date

Monday, November 27, 2023

Trademark Owner History

Matricelf Ltd.

Classifications

5 Biological implants; biological tissue for implantation; biological tissue cultures for medical purposes; engineered biological tissues for medical purposes; engineered human biological tissues for use in regenerative medicine; engineered biological tissues for the treatment of spinal cord injuries; biological implants for spinal cord injuries; bio-printed personalized medical implants comprised of living tissue; a personalized bio-printed medical tissue implant adapted to fill a surgically defined cavity; transplants [living tissues]; surgical implants comprising engineered living tissue; surgical implants grown from stem cells; engineered human hydrogel and differentiated stem cells in the nature of biological tissues for medical purposes; engineered human hydrogel for medical purposes; stem cells for medical purposes; biomaterials in the nature of biological tissue cells for printing engineered tissues for medical purposes

44 Regenerative medicine services; medical services, namely tissue regeneration services; medical services, namely tissue regeneration services using tissue engineering technology; medical services, namely, cellular therapy services; medical services, namely regenerating or restoration of spinal cord tissue by means of implanting engineered tissues in the spinal cord; treating human tissues for medical purposes [biomedical services]; medical services relating to the removal, treatment and processing of human tissues; medical services relating to the removal, treatment and processing of human tissues for implantation

42 Scientific services relating to processing human tissues and cells; medical and scientific research and development of human tissues and stem cells; medical and scientific research and development in the field of personalized medicine 3D bioprinting; stem cell research services; scientific and technological services in the field of regenerative medicine; medical and scientific research and development in the field of regenerative medicine; medical and scientific research and development in the field of spinal cord injuries; pharmaceutical and biological research and development services in the field of tissue regeneration and engineering

Trademark Events

Mar 14, 2024

Sn Assigned For Sect 66a Appl From Ib

Mar 20, 2024

New Application Office Supplied Data Entered

Apr 24, 2024

Application Filing Receipt Mailed

Jun 26, 2024

Assigned To Examiner

Jun 29, 2024

Non-Final Action Written

Jun 30, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Jul 25, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Jul 25, 2024

Refusal Processed By Mpu

Aug 11, 2024

Refusal Processed By Ib